Alpha Geek

(8)

$10/per page/Negotiable

About Alpha Geek

Levels Tought:
University

Expertise:
Accounting,Algebra See all
Accounting,Algebra,Architecture and Design,Art & Design,Biology,Business & Finance,Calculus,Chemistry,Communications,Computer Science,Environmental science,Essay writing,Programming,Social Science,Statistics Hide all
Teaching Since: Apr 2017
Last Sign in: 438 Weeks Ago, 1 Day Ago
Questions Answered: 9562
Tutorials Posted: 9559

Education

  • bachelor in business administration
    Polytechnic State University Sanluis
    Jan-2006 - Nov-2010

  • CPA
    Polytechnic State University
    Jan-2012 - Nov-2016

Experience

  • Professor
    Harvard Square Academy (HS2)
    Mar-2012 - Present

Category > Statistics Posted 19 May 2017 My Price 12.00

Breast Cancer Two drugs were tested to see whether

Breast Cancer Two drugs were tested to see whether they helped women who had breast cancer without lymph node involvement. The drugs are called TAC (docetaxel, doxorubicin, and cyclophosphamide) and FAC (fluorouracil, doxorubicin, and cyclophosphamide). About half of the 1060 women with breast cancer without lymph node involvement were randomly assigned to TAC, and the other half were assigned to FAC. After 77 months, 473 out of 539 of the women assigned to TAC were alive, and 426 out of 521 women assigned to FAC were alive. (Source: Martin et al., Adjuvant docetaxel for high-risk, node-negative breast cancer, New England Journal of Medicine, vol. 363, no. 23: 2200–10, December 2, 2010)

 

a. Find both sample percentages of survival, and compare them descriptively.

b. Was this a controlled experiment or an observational study? Explain why. From studies like these, can we conclude a cause-and-effect relationship between the drug type and the survival percentage? Why or why not?

 

Answers

(8)
Status NEW Posted 19 May 2017 10:05 AM My Price 12.00

-----------

Attachments

file 1495189642-Answer.docx preview (213 words )
B-----------rea-----------st -----------Can-----------cer----------- Tw-----------o d-----------rug-----------s w-----------ere----------- te-----------ste-----------d t-----------o s-----------ee -----------whe-----------the-----------r t-----------hey----------- he-----------lpe-----------d w-----------ome-----------n w-----------ho -----------had----------- br-----------eas-----------t c-----------anc-----------er -----------wit-----------hou-----------t l-----------ymp-----------h n-----------ode----------- in-----------vol-----------vem-----------ent-----------. T-----------he -----------dru-----------gs -----------are----------- ca-----------lle-----------d T-----------AC -----------(do-----------cet-----------axe-----------l, -----------dox-----------oru-----------bic-----------in,----------- an-----------d c-----------ycl-----------oph-----------osp-----------ham-----------ide-----------) a-----------nd -----------FAC----------- (f-----------luo-----------rou-----------rac-----------il,----------- do-----------xor-----------ubi-----------cin-----------, a-----------nd -----------cyc-----------lop-----------hos-----------pha-----------mid-----------e).----------- Ab-----------out----------- ha-----------lf -----------of -----------the----------- 10-----------60 -----------wom-----------en -----------wit-----------h b-----------rea-----------st -----------can-----------cer----------- wi-----------tho-----------ut -----------lym-----------ph -----------nod-----------e i-----------nvo-----------lve-----------men-----------t w-----------ere----------- ra-----------ndo-----------mly----------- as-----------sig-----------ned----------- to----------- TA-----------C, -----------and----------- th-----------e o-----------the-----------r h-----------alf----------- we-----------re -----------ass-----------ign-----------ed -----------to -----------FAC-----------. A-----------fte-----------r 7-----------7 m-----------ont-----------hs,----------- 47-----------3 o-----------ut
Not Rated(0)